Cargando…

Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance

SIMPLE SUMMARY: Melanoma is a highly metastatic and therapy-resistant cancer and is therefore associated with low survival rates of patients. In melanoma, the inactivation of the wild-type form of the p53 tumour suppressor protein is a frequent event, mainly through interactions with MDM2 and MDMX....

Descripción completa

Detalles Bibliográficos
Autores principales:	Loureiro, Joana B., Raimundo, Liliana, Calheiros, Juliana, Carvalho, Carla, Barcherini, Valentina, Lima, Nuno R., Gomes, Célia, Almeida, Maria Inês, Alves, Marco G., Costa, José Luís, Santos, Maria M. M., Saraiva, Lucília
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037490/ https://www.ncbi.nlm.nih.gov/pubmed/33916029 http://dx.doi.org/10.3390/cancers13071648

Ejemplares similares

SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner
por: Ramos, Helena, et al.
Publicado: (2020)

SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
por: Gomes, Sara, et al.
Publicado: (2019)

Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target
por: Raimundo, Liliana, et al.
Publicado: (2021)

DIMP53‐1: a novel small‐molecule dual inhibitor of p53–MDM2/X interactions with multifunctional p53‐dependent anticancer properties
por: Soares, Joana, et al.
Publicado: (2017)

Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators
por: Barcherini, Valentina, et al.
Publicado: (2023)

Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
por: Soares, Joana, et al.
Publicado: (2015)

Synthesis, Biological Evaluation, and In Silico Studies of Novel Aminated Xanthones as Potential p53-Activating Agents
por: Lemos, Agostinho, et al.
Publicado: (2019)

Counteracting Colon Cancer by Inhibiting Mitochondrial Respiration and Glycolysis with a Selective PKCδ Activator
por: Bessa, Cláudia, et al.
Publicado: (2023)

Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment
por: Almeida, Joana, et al.
Publicado: (2022)

Semi-Synthesis of Small Molecules of Aminocarbazoles: Tumor Growth Inhibition and Potential Impact on p53
por: Long, Solida, et al.
Publicado: (2021)

Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness
por: Moreira, Joana, et al.
Publicado: (2021)

Discovery of a small-molecule protein kinase Cδ-selective activator with promising application in colon cancer therapy
por: Bessa, Cláudia, et al.
Publicado: (2018)

Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells
por: Sancha, Shirley A. R., et al.
Publicado: (2022)

Structural and Drug Targeting Insights on Mutant p53
por: Gomes, Ana Sara, et al.
Publicado: (2021)

The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding
por: Gomes, Ana Sara, et al.
Publicado: (2018)

Comparison Study of Different Extracts of Plectranthus madagascariensis, P. neochilus and the Rare P. porcatus (Lamiaceae): Chemical Characterization, Antioxidant, Antimicrobial and Cytotoxic Activities
por: Matias, Diogo, et al.
Publicado: (2019)

Structure–Activity Relationship Studies of Chalcones and Diarylpentanoids with Antitumor Activity: Potency and Selectivity Optimization
por: Moreira, Joana, et al.
Publicado: (2023)

Tumour invasion and dissemination
por: Lusby, Ryan, et al.
Publicado: (2022)

Heart Dissemination: A Clinical Case of Melanoma
por: André, Diogo, et al.
Publicado: (2021)

Hydroxytyrosol Counteracts Triple Negative Breast Cancer Cell Dissemination via Its Copper Complexing Properties
por: Perta, Nunzio, et al.
Publicado: (2023)

Homeostatic membrane tension constrains cancer cell dissemination by counteracting BAR protein assembly
por: Tsujita, Kazuya, et al.
Publicado: (2021)

Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei
por: Cerqueira, Fátima, et al.
Publicado: (2021)

Counteracting oxidative phosphorylation-mediated resistance of melanomas to MAPK pathway inhibition
por: McQuade, Jennifer L, et al.
Publicado: (2015)

Climacostol reduces tumour progression in a mouse model of melanoma via the p53-dependent intrinsic apoptotic programme
por: Perrotta, Cristiana, et al.
Publicado: (2016)

3-(1,2,3-Triazol-4-yl)-β-Carbolines and 3-(1H-Tetrazol-5-yl)-β-Carbolines: Synthesis and Evaluation as Anticancer Agents
por: Ribeiro, João L. P., et al.
Publicado: (2022)

Bioactive Diarylpentanoids: Insights into the Biological Effects beyond Antitumor Activity and Structure–Activity Relationships
por: Moreira, Joana, et al.
Publicado: (2022)

Disseminated Cancer in Pregnancy: Krukenberg Tumour
por: Kim, Sung-Hee, et al.
Publicado: (2014)

Modes of invasion during tumour dissemination
por: Pandya, Pahini, et al.
Publicado: (2016)

Tumour-infiltrating neutrophils counteract anti-VEGF therapy in metastatic colorectal cancer
por: Schiffmann, Lars Mortimer, et al.
Publicado: (2018)

P-cadherin counteracts myosin II-B function: implications in melanoma progression
por: Jacobs, Koen, et al.
Publicado: (2010)

Fatal Disseminated Kaposi’s Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection Fatal Disseminated Kaposi’s Sarcoma in Two Patients with Human Immunodeficiency Virus (HIV) Infection
por: Fardin, Rafaela Barbirato, et al.
Publicado: (2018)

Contribution of Yeast Models to Neurodegeneration Research
por: Pereira, Clara, et al.
Publicado: (2012)

P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
por: Kovács, J, et al.
Publicado: (2014)

The Therapeutic Potential of Naturally Occurring Peptides in Counteracting SH-SY5Y Cells Injury
por: Perlikowska, Renata, et al.
Publicado: (2022)

Tumour to Tumour Metastasis of Malignant Melanoma to Intracranial Tumour
por: Shariff, Zakir, et al.
Publicado: (2009)

A fatal pseudo-tumour: disseminated basidiobolomycosis
por: van den Berk, Guido EL, et al.
Publicado: (2006)

Vascular niches for disseminated tumour cells in bone
por: Kusumbe, Anjali P.
Publicado: (2016)

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development
por: Alonso-Curbelo, Direna, et al.
Publicado: (2015)

Disseminating melanoma cells surf on calcium waves
por: Sun, Jianwei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jk9cuqaihh91ht27tf4sneqadu